These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibition of carrageenan-induced spinal c-Fos activation by systemically administered c-fos antisense oligodeoxynucleotides may be facilitated by local opening of the blood-spinal cord barrier. Gillardon F; Vogel J; Hein S; Zimmermann M; Uhlmann E J Neurosci Res; 1997 Mar; 47(6):582-9. PubMed ID: 9089206 [TBL] [Abstract][Full Text] [Related]
25. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence. Sarabia SF; Liehr JG Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862 [TBL] [Abstract][Full Text] [Related]
26. c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism. Bussolino DF; Guido ME; Gil GA; Borioli GA; Renner ML; Grabois VR; Conde CB; Caputto BL FASEB J; 2001 Mar; 15(3):556-8. PubMed ID: 11259365 [TBL] [Abstract][Full Text] [Related]
27. Antisense promoter mapping. Inhibitory methods of transcriptional analysis. Holt JT Ann N Y Acad Sci; 1992 Oct; 660():88-94. PubMed ID: 1340160 [TBL] [Abstract][Full Text] [Related]
28. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800 [TBL] [Abstract][Full Text] [Related]
29. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Hipskind RA; Rao VN; Mueller CG; Reddy ES; Nordheim A Nature; 1991 Dec 19-26; 354(6354):531-4. PubMed ID: 1722028 [TBL] [Abstract][Full Text] [Related]
30. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos. Touray M; Ryan F; Saurer S; Martin F; Jaggi R Oncogene; 1991 Feb; 6(2):211-7. PubMed ID: 1847998 [TBL] [Abstract][Full Text] [Related]
31. Interleukin 6-induced differentiation of a human B cell line into IgM-secreting plasma cells is mediated by c-fos. Körholz D; Gerdau S; Enczmann J; Zessack N; Burdach S Eur J Immunol; 1992 Feb; 22(2):607-10. PubMed ID: 1537389 [TBL] [Abstract][Full Text] [Related]
32. c-fos expression is required during all phases of the cell cycle during exponential cell proliferation. Pai SR; Bird RC Anticancer Res; 1994; 14(3A):985-94. PubMed ID: 8074503 [TBL] [Abstract][Full Text] [Related]
33. The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription. Schönthal A; Büscher M; Angel P; Rahmsdorf HJ; Ponta H; Hattori K; Chiu R; Karin M; Herrlich P Oncogene; 1989 May; 4(5):629-36. PubMed ID: 2498806 [TBL] [Abstract][Full Text] [Related]
34. Involvement of fos in spontaneous and ultraviolet light-induced genetic changes. van den Berg S; Kaina B; Rahmsdorf HJ; Ponta H; Herrlich P Mol Carcinog; 1991; 4(6):460-6. PubMed ID: 1793485 [TBL] [Abstract][Full Text] [Related]
35. Antisense rescue defines specialized and generalized functional domains for c-Fos protein. Holt JT Mol Cell Biol; 1993 Jun; 13(6):3821-30. PubMed ID: 8497282 [TBL] [Abstract][Full Text] [Related]
36. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM; Providence KM; Higgins PJ Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948 [TBL] [Abstract][Full Text] [Related]
37. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Su ZZ; Yemul S; Stein CA; Fisher PB Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104 [TBL] [Abstract][Full Text] [Related]
38. cFos is critical for MCF-7 breast cancer cell growth. Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729 [TBL] [Abstract][Full Text] [Related]
39. Gene transplantation: combined antisense inhibition and gene replacement strategies. Robinson-Benion C; Li YX; Holt JT Leukemia; 1994 Apr; 8 Suppl 1():S152-5. PubMed ID: 8152283 [TBL] [Abstract][Full Text] [Related]